Sort by
Interaction of Myopic Optic Neuropathy (MON) and Glaucomatous Optic Neuropathy (GON): Pathophysiology and Clinical Implications
Etsuo Chihara
Posted: 14 January 2026
Surgical Outcomes of Epiretinal Human Amniotic Membrane Transplantation for Refractory Macular Holes
Sibel Doguizi
,Cemile Ucgul Atilgan
,Kemal Tekin
Posted: 13 January 2026
Automated Videotopography for Dry Eye Diagnostics: Analytical Performance, Spatial Dynamics, and a Novel Multivariate Model
Daniela Oehring
Posted: 08 January 2026
Perimetry of the Central Visual Field Using a Head-Mounted Open-Source Perimeter in Patients with Inherited Retinal Diseases
Cord Huchzermeyer
,Friedrich Kruse
,Jan Kremers
Posted: 08 January 2026
Clinical Outcomes of the Eight-Chop Technique in White Cataract: A Retrospective Case Seriese
Tsuyoshi Sato
Objectives: White cataracts present substantial technical challenges during phacoemulsification because nuclear hardness cannot be assessed preoperatively and the risk of intraoperative complications is increased. This study aimed to evaluate the surgical efficiency, safety, and postoperative outcomes of the eight-chop technique in eyes with white cataracts across different levels of intraoperative nuclear hardness. Methods: This retrospective, single-center, single-surgeon observational study included eyes with white cataracts that underwent phacoemulsification using the eight-chop technique between January 4, 2010, and March 25, 2025. White cataract was defined as a completely white and opaque lens with absent red reflex on slit-lamp examination. Nuclear hardness was classified intraoperatively according to the Emery classification. Intraoperative parameters, corneal endothelial cell density (CECD), corneal endothelial morphology, intraocular pressure (IOP), and best-corrected visual acuity (BCVA) were evaluated preoperatively and postoperatively. Outcomes were compared among nuclear hardness groups. Results: Among 12,642 cataract surgeries performed during the study period, 126 eyes were diagnosed with white cataracts. After exclusions, 105 eyes were included in the final analysis. Operative time, phacoemulsification time, and cumulative dissipated energy increased significantly with nuclear hardness (all p < 0.01), whereas aspiration time and irrigation fluid volume did not differ significantly among groups. CECD loss at 7 and 19 weeks postoperatively was minimal, with no significant differences among hardness groups. Transient changes in corneal endothelial morphology were observed postoperatively but resolved by 19 weeks. Postoperative IOP decreased significantly in eyes with higher nuclear hardness. BCVA improved markedly in all groups, and differences observed in the early postoperative period disappeared over time. Posterior capsule rupture occurred in 2 of 105 eyes, and no cases of dropped nucleus were observed. Conclusions: The eight-chop technique enables safe and efficient phacoemulsification in eyes with white cataracts across a wide range of nuclear hardness. This technique minimizes ultrasound energy and corneal endothelial damage while providing favorable visual outcomes and acceptable complication rates, even in advanced cases.
Objectives: White cataracts present substantial technical challenges during phacoemulsification because nuclear hardness cannot be assessed preoperatively and the risk of intraoperative complications is increased. This study aimed to evaluate the surgical efficiency, safety, and postoperative outcomes of the eight-chop technique in eyes with white cataracts across different levels of intraoperative nuclear hardness. Methods: This retrospective, single-center, single-surgeon observational study included eyes with white cataracts that underwent phacoemulsification using the eight-chop technique between January 4, 2010, and March 25, 2025. White cataract was defined as a completely white and opaque lens with absent red reflex on slit-lamp examination. Nuclear hardness was classified intraoperatively according to the Emery classification. Intraoperative parameters, corneal endothelial cell density (CECD), corneal endothelial morphology, intraocular pressure (IOP), and best-corrected visual acuity (BCVA) were evaluated preoperatively and postoperatively. Outcomes were compared among nuclear hardness groups. Results: Among 12,642 cataract surgeries performed during the study period, 126 eyes were diagnosed with white cataracts. After exclusions, 105 eyes were included in the final analysis. Operative time, phacoemulsification time, and cumulative dissipated energy increased significantly with nuclear hardness (all p < 0.01), whereas aspiration time and irrigation fluid volume did not differ significantly among groups. CECD loss at 7 and 19 weeks postoperatively was minimal, with no significant differences among hardness groups. Transient changes in corneal endothelial morphology were observed postoperatively but resolved by 19 weeks. Postoperative IOP decreased significantly in eyes with higher nuclear hardness. BCVA improved markedly in all groups, and differences observed in the early postoperative period disappeared over time. Posterior capsule rupture occurred in 2 of 105 eyes, and no cases of dropped nucleus were observed. Conclusions: The eight-chop technique enables safe and efficient phacoemulsification in eyes with white cataracts across a wide range of nuclear hardness. This technique minimizes ultrasound energy and corneal endothelial damage while providing favorable visual outcomes and acceptable complication rates, even in advanced cases.
Posted: 01 January 2026
Carbon Monoxide Therapy: Evidence and Prospects for Preventing and Treating Ocular Diseases
Matthew Reese Land
,Marybeth Koepsell
,Noah Nussbaum
,Edward Gomperts
,Andrew Gomperts
,Menaka C. Thounaojam
,Ravirajsinh N. Jadeja
,Pamela M. Martin
Carbon monoxide (CO) therapy involves the controlled administration of low doses of CO to harness its cytoprotective properties, including anti-inflammatory, anti-apoptotic, and vasodilatory effects. Originally studied for its role in cardiovascular and pulmonary conditions, CO therapy is now being explored for its potential in treating ocular diseases. Traditionally recognized for its toxic effects, carbon monoxide is gaining attention as a promising therapeutic agent in ocular medicine. Controlled, low-dose CO therapy has demonstrated anti-inflammatory and anti-apoptotic benefits in various models of retinal disease, including retinal ischemia-reperfusion injury, optic nerve crush, ocular hypertension, and autoimmune uveitis. This review summarizes key findings from clinical and preclinical studies, highlighting the therapeutic potential of CO. We also explore current and emerging methods of CO delivery, evaluating their safety, efficacy, and applicability in treating retinal disorders.
Carbon monoxide (CO) therapy involves the controlled administration of low doses of CO to harness its cytoprotective properties, including anti-inflammatory, anti-apoptotic, and vasodilatory effects. Originally studied for its role in cardiovascular and pulmonary conditions, CO therapy is now being explored for its potential in treating ocular diseases. Traditionally recognized for its toxic effects, carbon monoxide is gaining attention as a promising therapeutic agent in ocular medicine. Controlled, low-dose CO therapy has demonstrated anti-inflammatory and anti-apoptotic benefits in various models of retinal disease, including retinal ischemia-reperfusion injury, optic nerve crush, ocular hypertension, and autoimmune uveitis. This review summarizes key findings from clinical and preclinical studies, highlighting the therapeutic potential of CO. We also explore current and emerging methods of CO delivery, evaluating their safety, efficacy, and applicability in treating retinal disorders.
Posted: 30 December 2025
Downregulating Nrl Expression and Rod Photoreceptor Protection
Yiwen Li
,Shuliang Jiao
,Weng Tao
,Rong Wen
Retinitis pigmentosa (RP) is a genetically heterogeneous group of inherited retinal degenerations with primary degeneration of rod photoreceptors followed by secondary cone loss. We investigated whether downregulating Nrl (neural retina leucine zipper), a key transcription factor specifying rod fate, can reprogram rods into a more resilient state. In a transgenic NrlN/N mouse in which Nrl was markedly downregulated, rod phenotype became more like rod-precursor, particularly in the inferior retina. Crossing NrlN/N mice with two rod-degeneration models, rd1 (Pde6brd1/rd1) and rhodopsin P23H knock-in (RhoP23H/P23H) mice, resulted in significantly improved photoreceptor survival in double mutant mice. In addition, AAV-mediated delivery of shRNA targeting Nrl mRNA substantially enhanced photoreceptor survival in rd10 (Pde6brd10/rd10) mice. These findings demonstrate that downregulation of Nrl reprograms rods and confers broad resistance to degeneration across multiple RP models. AAV-mediated Nrl knockdown represents a promising mutation-independent therapeutic strategy for autosomal recessive and dominant forms of RP.
Retinitis pigmentosa (RP) is a genetically heterogeneous group of inherited retinal degenerations with primary degeneration of rod photoreceptors followed by secondary cone loss. We investigated whether downregulating Nrl (neural retina leucine zipper), a key transcription factor specifying rod fate, can reprogram rods into a more resilient state. In a transgenic NrlN/N mouse in which Nrl was markedly downregulated, rod phenotype became more like rod-precursor, particularly in the inferior retina. Crossing NrlN/N mice with two rod-degeneration models, rd1 (Pde6brd1/rd1) and rhodopsin P23H knock-in (RhoP23H/P23H) mice, resulted in significantly improved photoreceptor survival in double mutant mice. In addition, AAV-mediated delivery of shRNA targeting Nrl mRNA substantially enhanced photoreceptor survival in rd10 (Pde6brd10/rd10) mice. These findings demonstrate that downregulation of Nrl reprograms rods and confers broad resistance to degeneration across multiple RP models. AAV-mediated Nrl knockdown represents a promising mutation-independent therapeutic strategy for autosomal recessive and dominant forms of RP.
Posted: 29 December 2025
The Eight-Chop Technique: Mechanistic Principles and Clinical Performance of a Segmentation-First Phacoemulsification Strategy
Tsuyoshi Sato
Posted: 24 December 2025
Hypotony-Related Optic Disc Oedema in a Patient with Juvenile Idiopathic Arthritis-Associated Uveitis and Idiopathic Intracranial Hypertension
Wei Jia Liu
,Jasvir Virdee
Ocular hypotony is an uncommon but vision-threatening cause of optic disc oedema. We present a case of a young woman with a complex ophthalmic history, including juvenile idiopathic arthritis (JIA), JIA-associated uveitis, secondary glaucoma, and suspected idiopathic intracranial hypertension, who developed significant hypotony-related optic disc oedema on a background of mild bilateral disc swelling. The case emphasises the importance of recognising hypotony maculopathy as a differential diagnosis for disc swelling, particularly in patients with fluctuating intraocular pressure and coexisting inflammatory eye disease. We discuss the concepts of the translaminar pressure gradient and its role in the development of optic disc oedema in the presence of both ocular hypotony and probable raised intracranial pressure.
Ocular hypotony is an uncommon but vision-threatening cause of optic disc oedema. We present a case of a young woman with a complex ophthalmic history, including juvenile idiopathic arthritis (JIA), JIA-associated uveitis, secondary glaucoma, and suspected idiopathic intracranial hypertension, who developed significant hypotony-related optic disc oedema on a background of mild bilateral disc swelling. The case emphasises the importance of recognising hypotony maculopathy as a differential diagnosis for disc swelling, particularly in patients with fluctuating intraocular pressure and coexisting inflammatory eye disease. We discuss the concepts of the translaminar pressure gradient and its role in the development of optic disc oedema in the presence of both ocular hypotony and probable raised intracranial pressure.
Posted: 23 December 2025
Patterns of Inflammation in Experimental Autoimmune Uveitis and Their Correlation to Optical Coherence Tomography Findings in Human Uveitis
Benedikt Schworm
,Tarek Ghannoum
,Stephan Thurau
,Gerhild Wildner
Posted: 18 December 2025
Effects of the Eight-Chop Technique in Phacoemulsification on Intraocular Pressure in Patients with Primary Open-Angle Glaucoma and Controls
Tsuyoshi Sato
Posted: 17 December 2025
Long-Term Effects of the Eight-Chop Technique in Phacoemulsification on Intraocular Pressure for Cataract Patients
Tsuyoshi Sato
Posted: 16 December 2025
Modulating One-Carbon Metabolism with B-Vitamins to Protect the Retinal Barrier and Prevent Retinal Degeneration
Hossameldin Abouhish
,Lamiaa Shalaby
,Omar Elzayat
,Neelesh Peddireddy
,Amany Tawfik*
Vitamin B12 deficiency is increasingly recognized as a contributor in both vascular and neurodegenerative aging-related disorders. Its deficiency disrupts one-carbon metabolism, leading to impaired homocysteine (Hcy) cycling. Elevated Hcy is a well-established risk factor for vascular dysfunction. Previously, we established that elevated Hcy contributes to aging retinal diseases and plays a central role in blood retinal barrier (BRB) dysfunction. Building on this foundation, the present study examines how B-vitamin deficiency disrupts one-carbon metabolism and whether restoring these vitamins can serve as a preventive or therapeutic strategy. Since B-vitamins (B6, B9, and B12) are crucial cofactors in the metabolism of Hcy, we investigated how dietary changes in these vitamins affect serum Hcy levels and retinal vascular integrity in mice. C57BL/6- Wild-type (WT) mice were fed specially formulated diets, which contained different levels of B-vitamins (normal, deficient (B-Vit (-)) or enriched (B-Vit (+)). Initially, two groups of mice were placed on either a normal or a deficient diet. After 12-16 weeks, the success of the diet regimes was confirmed by observing serum B12 deficiency in the B-Vit (-) group, along with elevated Hcy levels. Subsequently, a subgroup of the B-Vit (-) mice was switched to an enriched diet. The BRB integrity was evaluated in living mice using fluorescein angiography (FA), optical coherence tomography (OCT), and in the perfused mice retinas with western blot analysis of leaked retinal albumin and tight junction proteins (occludin and ZO-1) levels. The B-vitamins deficiency caused significant drop in serum vitamin B12 and an increase in plasma Hcy, leading to vascular leakage, altered retinal thickness, choroidal neovascular changes, increased retinal albumin leak, and decreased tight junction proteins expression, indicating BRB disruption, which was restored with B-vitamin supplementation. In conclusion, a long-term deficiency of vitamins B6, B9, and B12 can lead to disruptions in the BRB. However, supplementation with these B-vitamins has the potential to reverse these effects and help maintain the integrity of BRB. This under-score the significance of one-carbon metabolism for retinal health and suggests that ensuring adequate levels of B-vitamins may aid in preventing aging retinal diseases with BRB disruption such as diabetic retinopathy and age-related macular degeneration.
Vitamin B12 deficiency is increasingly recognized as a contributor in both vascular and neurodegenerative aging-related disorders. Its deficiency disrupts one-carbon metabolism, leading to impaired homocysteine (Hcy) cycling. Elevated Hcy is a well-established risk factor for vascular dysfunction. Previously, we established that elevated Hcy contributes to aging retinal diseases and plays a central role in blood retinal barrier (BRB) dysfunction. Building on this foundation, the present study examines how B-vitamin deficiency disrupts one-carbon metabolism and whether restoring these vitamins can serve as a preventive or therapeutic strategy. Since B-vitamins (B6, B9, and B12) are crucial cofactors in the metabolism of Hcy, we investigated how dietary changes in these vitamins affect serum Hcy levels and retinal vascular integrity in mice. C57BL/6- Wild-type (WT) mice were fed specially formulated diets, which contained different levels of B-vitamins (normal, deficient (B-Vit (-)) or enriched (B-Vit (+)). Initially, two groups of mice were placed on either a normal or a deficient diet. After 12-16 weeks, the success of the diet regimes was confirmed by observing serum B12 deficiency in the B-Vit (-) group, along with elevated Hcy levels. Subsequently, a subgroup of the B-Vit (-) mice was switched to an enriched diet. The BRB integrity was evaluated in living mice using fluorescein angiography (FA), optical coherence tomography (OCT), and in the perfused mice retinas with western blot analysis of leaked retinal albumin and tight junction proteins (occludin and ZO-1) levels. The B-vitamins deficiency caused significant drop in serum vitamin B12 and an increase in plasma Hcy, leading to vascular leakage, altered retinal thickness, choroidal neovascular changes, increased retinal albumin leak, and decreased tight junction proteins expression, indicating BRB disruption, which was restored with B-vitamin supplementation. In conclusion, a long-term deficiency of vitamins B6, B9, and B12 can lead to disruptions in the BRB. However, supplementation with these B-vitamins has the potential to reverse these effects and help maintain the integrity of BRB. This under-score the significance of one-carbon metabolism for retinal health and suggests that ensuring adequate levels of B-vitamins may aid in preventing aging retinal diseases with BRB disruption such as diabetic retinopathy and age-related macular degeneration.
Posted: 09 December 2025
IOL Power Calculation by Ray Tracing in Eyes with Previous Radial Keratotomy
Giacomo Savini
,Kenneth J Hoffer
,Arianna Grendele
,Catarina P. Coutinho
,Andrea Russo
,Domenico Schiano-Lomoriello
Posted: 09 December 2025
Does Lowering Intraoperative Intraocular Pressure Reduce Surgical Invasiveness in Active-Fluidics Eight-Chop Phacoemulsification? A Fellow-Eye Comparative Study
Tsuyoshi Sato
Background: Active-fluidics phacoemulsification can maintain anterior chamber stability at lower intraoperative intraocular pressure (IOP) levels. However, whether reducing IOP alone—without additional stabilizing technologies such as the Active Sentry handpiece—can decrease surgical invasiveness during Eight-Chop technique phacoemulsification remains unclear. Methods: In this prospective fellow-eye comparative study, 56 non-diabetic patients (112 eyes) underwent Eight-Chop technique phacoemulsification using the Centurion Vision System with active fluidics. One eye was randomly assigned to a standard-IOP setting (55 mmHg; high-IOP group) and the fellow eye to a reduced-IOP setting (28 mmHg; low-IOP group). Intraoperative parameters—including operative time, phaco time, aspiration time, cumulative dissipated energy (CDE), and irrigation volume—were recorded. Postoperative outcomes included aqueous flare (laser flare photometry), corneal endothelial cell density (CECD) and CECD loss, corneal morphology (central corneal thickness [CCT], coefficient of variation [CV], percentage of hexagonal cells [PHC]), and IOP. Linear mixed-effects models with patient ID as a random effect were used for all paired-eye comparisons. Results: Lowering the intraoperative IOP did not reduce surgical invasiveness. Phaco time was significantly longer in the low-IOP group (16.2 ± 5.22 s vs 13.9 ± 4.40 s; p = 0.001), and aspiration time was also longer (75.0 ± 18.3 s vs 69.0 ± 17.9 s; p = 0.033). No significant differences were found in operative time (5.08 ± 1.10 min vs 4.82 ± 1.13 min; p = 0.082), CDE (5.93 ± 1.87 vs 5.56 ± 1.90; p = 0.099), or irrigation volume (26.6 ± 7.71 mL vs 25.2 ± 7.35 mL; p = 0.214). Postoperative outcomes were similarly comparable. Aqueous flare showed no significant differences at any time point (e.g., day 1: 14.8 ± 5.10 vs 14.5 ± 4.76 ph/ms; p = 0.655). Mean CECD loss remained small in both groups and did not differ significantly (7 weeks: -0.82 ± 1.05% vs -0.98 ± 1.16%, p = 0.460; 19 weeks: -0.93 ± 1.38% vs -1.28 ± 1.69%, p = 0.239). Corneal morphological parameters (CCT, CV, PHC) and postoperative IOP also showed no significant differences between settings. Conclusions: When used with the Eight-Chop technique and active fluidics, lowering intraoperative IOP to near-physiologic levels did not decrease surgical invasiveness and did not provide measurable improvements in postoperative inflammation, CECD loss, or structural corneal outcomes. The present results suggest that reducing IOP alone—without supplemental stabilizing technologies—does not enhance tissue protection during phacoemulsification.
Background: Active-fluidics phacoemulsification can maintain anterior chamber stability at lower intraoperative intraocular pressure (IOP) levels. However, whether reducing IOP alone—without additional stabilizing technologies such as the Active Sentry handpiece—can decrease surgical invasiveness during Eight-Chop technique phacoemulsification remains unclear. Methods: In this prospective fellow-eye comparative study, 56 non-diabetic patients (112 eyes) underwent Eight-Chop technique phacoemulsification using the Centurion Vision System with active fluidics. One eye was randomly assigned to a standard-IOP setting (55 mmHg; high-IOP group) and the fellow eye to a reduced-IOP setting (28 mmHg; low-IOP group). Intraoperative parameters—including operative time, phaco time, aspiration time, cumulative dissipated energy (CDE), and irrigation volume—were recorded. Postoperative outcomes included aqueous flare (laser flare photometry), corneal endothelial cell density (CECD) and CECD loss, corneal morphology (central corneal thickness [CCT], coefficient of variation [CV], percentage of hexagonal cells [PHC]), and IOP. Linear mixed-effects models with patient ID as a random effect were used for all paired-eye comparisons. Results: Lowering the intraoperative IOP did not reduce surgical invasiveness. Phaco time was significantly longer in the low-IOP group (16.2 ± 5.22 s vs 13.9 ± 4.40 s; p = 0.001), and aspiration time was also longer (75.0 ± 18.3 s vs 69.0 ± 17.9 s; p = 0.033). No significant differences were found in operative time (5.08 ± 1.10 min vs 4.82 ± 1.13 min; p = 0.082), CDE (5.93 ± 1.87 vs 5.56 ± 1.90; p = 0.099), or irrigation volume (26.6 ± 7.71 mL vs 25.2 ± 7.35 mL; p = 0.214). Postoperative outcomes were similarly comparable. Aqueous flare showed no significant differences at any time point (e.g., day 1: 14.8 ± 5.10 vs 14.5 ± 4.76 ph/ms; p = 0.655). Mean CECD loss remained small in both groups and did not differ significantly (7 weeks: -0.82 ± 1.05% vs -0.98 ± 1.16%, p = 0.460; 19 weeks: -0.93 ± 1.38% vs -1.28 ± 1.69%, p = 0.239). Corneal morphological parameters (CCT, CV, PHC) and postoperative IOP also showed no significant differences between settings. Conclusions: When used with the Eight-Chop technique and active fluidics, lowering intraoperative IOP to near-physiologic levels did not decrease surgical invasiveness and did not provide measurable improvements in postoperative inflammation, CECD loss, or structural corneal outcomes. The present results suggest that reducing IOP alone—without supplemental stabilizing technologies—does not enhance tissue protection during phacoemulsification.
Posted: 09 December 2025
Intraocular Inflammation Following Intravitreal Faricimab: A Systematic Review and Meta-analysis
Jumanah Qedair
,Asmaa A.Youssif
,Reham Shehada
,Hashem Abu Serhan
Posted: 08 December 2025
Biofeedback Fixation Training in the Rehabilitation of Patients with Geographic Atrophy
Kristof Voros
,Illes Kovacs
,Greta Kezdy
,Agnes Elo
,Zsuzsa Szilagyi
,Mirella Barboni
,Zsuzsa Récsán
,Zoltán Zsolt Nagy
,Monika Ecsedy
Posted: 03 December 2025
Postoperative Flare and Corneal Endothelial Cell Loss After Eight-Chop Technique Phacoemulsification: A Prospective Observational Study
Tsuyoshi Sato
Posted: 02 December 2025
The Role of Pilocarpine Eye Drops in the Management of Presbyopia: A Systematic Review
Khaldon Abbas
,Karanvir Gill
,Tiba Al-Helli
,Pratik Gajiwala
,Arshdeep Judgey
,Ahmed Abbas
,Mohammed Alenazi
,Mona Koaik
Posted: 27 November 2025
Objective Macular Asymmetry Metrics for Glaucoma Detection Using a Temporal Raphe–Based OCT Linearization Algorithm
Takuhei Shoji
,Miho Seo
,Hisashi Ibuki
,Hirokazu Ishii
,Junji Kanno
,Kei Shinoda
Posted: 24 November 2025
of 20